Clinical Trial Update: Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of inobrodib, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Inobrodib (Inobrodib)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: CellCentric Ltd. | Conditions: Multiple Myeloma Refractory, Multiple Myeloma in Relapse | Phase 2 | Status: RECRUITING